HRT Financial’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-582,228
| Closed | -$29.1M | – | 4660 |
|
|
2025
Q4 | $29.1M | Buy |
582,228
+380,798
| +189% | +$18.3M | 0.09% | 155 |
|
|
2025
Q3 | $9.89M | Buy |
201,430
+107,259
| +114% | +$5.5M | 0.04% | 403 |
|
|
2025
Q2 | $4.87M | Sell |
94,171
-258,540
| -73% | -$11.9M | 0.02% | 546 |
|
|
2025
Q1 | $16.5M | Buy |
352,711
+278,438
| +375% | +$14.4M | 0.1% | 146 |
|
|
2024
Q4 | $3.81M | Sell |
74,273
-75,746
| -50% | -$3.92M | 0.02% | 488 |
|
|
2024
Q3 | $6.67M | Buy |
+150,019
| New | +$6.56M | 0.03% | 345 |
|
|
2023
Q4 | – | Sell |
-20,855
| Closed | -$579K | – | 3020 |
|
|
2023
Q3 | $579K | Buy |
+20,855
| New | +$652K | 0.01% | 1328 |
|
|
2022
Q3 | – | Sell |
-33,622
| Closed | -$1.21M | – | 3454 |
|
|
2022
Q2 | $1.21M | Buy |
+33,622
| New | +$1.39M | 0.01% | 802 |
|
|
2022
Q1 | – | Sell |
-17,673
| Closed | -$846K | – | 3803 |
|
|
2021
Q4 | $846K | Sell |
17,673
-33,185
| -65% | -$1.57M | ﹤0.01% | 1277 |
|
|
2021
Q3 | $2.23M | Buy |
50,858
+23,890
| +89% | +$1.01M | 0.01% | 664 |
|
|
2021
Q2 | $1.18M | Buy |
+26,968
| New | +$1.27M | 0.01% | 911 |
|
|
2021
Q1 | – | Sell |
-40,235
| Closed | -$1.3M | – | 3112 |
|
|
2020
Q4 | $1.3M | Buy |
40,235
+22,818
| +131% | +$660K | 0.03% | 495 |
|
|
2020
Q3 | $368K | Buy |
+17,417
| New | +$363K | 0.01% | 1030 |
|
|
2019
Q4 | – | Sell |
-49,213
| Closed | -$1.76M | – | 1601 |
|
|
2019
Q3 | $1.76M | Buy |
49,213
+24,541
| +99% | +$880K | 0.08% | 205 |
|
|
2019
Q2 | $863K | Buy |
+24,672
| New | +$858K | 0.05% | 302 |
|
|
2018
Q4 | – | Sell |
-9,662
| Closed | -$442K | – | 740 |
|
|
2018
Q3 | $442K | Buy |
+9,662
| New | +$486K | 0.07% | 192 |
|
Other funds holding SNV
HRT Financial's SNV Position: Q1 2026 in Review
HRT Financial sold out of Synovus (SNV) in Q1 2026, closing a stake of 582,228 shares — an estimated $29.1M sold.
HRT Financial first reported a position in SNV in Q3 2018 and held it in 16 quarters. The position peaked at $29.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- HRT Financial reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- HRT Financial sold 582,228 Synovus shares in Q1 2026, an estimated $29.1M.
- HRT Financial first reported a position in Synovus in Q3 2018 and held it in 16 quarters.
- HRT Financial's Synovus position peaked at $29.1M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.